**Executive Summary**
The Department of Pharmaceuticals organized a webinar on April 4, 2026, as part of Sādhana Saptah (April 2–8, 2026), to explore the transformative role of Artificial Intelligence (AI) in drug discovery and regulation. Led by Prof. Manoj Kumar of NIPER Mohali, the session focused on integrating emerging technologies to enhance the pharmaceutical value chain and government regulatory efficiency. The initiative aims to build capacity within government systems to accelerate approval pathways and strengthen India’s global pharmaceutical leadership.
**Key Points / Main Content**
* **AI Integration Across the Pharmaceutical Lifecycle**
* **Research & Development:** Facilitates more accurate target identification and lead optimization.
* **Pre-clinical Studies:** Employs AI-enabled simulations for advanced in vitro and in vivo modelling.
* **Clinical Trials:** Improves trial design, patient stratification, and the use of advanced data analytics.
* **Regulatory Review:** Enhances evidence generation and provides AI-enabled decision support systems for faster approvals.
* **Advancements in Drug Discovery and Synthesis**
* Prediction of 3D protein structures and complex drug–target interactions.
* Utilization of AI for de novo molecule generation and AI-driven drug design.
* Application of AI in polypharmacology and multi-target drug development.
* Prediction of chemical synthesis and retrosynthetic pathways to streamline production.
* Identification of drug repurposing opportunities and therapeutic targets.
* **Efficiency and Early-Stage Research**
* Significant reduction in time and costs associated with early-stage drug discovery.
* Faster screening of compounds and improved prediction of toxicity, bioactivity, and physicochemical properties.
* **Strategic Government Objectives**
* Building internal capacity to leverage AI for evidence-based regulatory decision-making.
* Enhancing drug safety monitoring and post-market surveillance through automated systems.
* Fostering a future-ready civil service through the "Mission Karmayogi" and Sādhana Saptah initiatives.
**Impact Analysis**
**Department of Pharmaceuticals (DoP) and Government Officers**
**Impact**
Officers are being equipped with technical knowledge to modernize regulatory frameworks and adopt citizen-centric governance tools.
**Action Required**
Engage in capacity-building initiatives to integrate AI into evidence-based decision-making and post-market surveillance.
**Pharmaceutical Industry and Researchers**
**Impact**
The sector stands to benefit from reduced R&D costs, faster compound screening, and clearer regulatory pathways.
**Action Required**
Adopt emerging AI technologies for drug design, molecule generation, and clinical trial optimization to maintain global competitiveness.
**Regulatory Bodies**
**Impact**
Regulators will transition toward AI-enabled support systems, allowing for accelerated drug approval processes without compromising safety.
**Action Required**
Develop and implement AI-driven protocols for evidence generation and monitoring to support the pharmaceutical ecosystem.
Key Entities Referenced
Sādhana Saptah 2026: A collaborative national capacity-building initiative (Strengthening Adaptive Development and Humane Aptitude for National Advancement) aimed at fostering skills for citizen-centric governance.
Mission Karmayogi: India's national program for civil services capacity building, reinforced by the Sādhana Saptah initiative to build a future-ready and accountable civil service.
Department of Pharmaceuticals: The primary government department responsible for fostering innovation and promoting the adoption of AI and emerging technologies within India's pharmaceutical ecosystem.
Capacity Building Commission: The central body spearheading the Sādhana Saptah initiative and responsible for driving government-wide capacity-building efforts and governance reform.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
Department of Pharmaceuticals Organises
Webinar On AI-Driven Innovations on Day 3 of
Sādhana Saptah 2026
Webinar Highlights Transformative Role of AI in Drug
Discovery, Development and Regulation
AI & Emerging Technologies to Strengthen India’s Pharma
Ecosystem
Posted On: 04 APR 2026 7:00PM by PIB Delhi
As part of the ongoing Sādhana Saptah 2026, the Department of Pharmaceuticals (DoP), Ministry of
Chemicals and Fertilizers, Government of India, organised a webinar today on “AI and Emerging
Technologies in Pharmaceuticals and Regulations”.
The webinar highlighted the transformative potential of Artificial Intelligence (AI) across the
pharmaceutical value chain, spanning drug discovery, development, and regulatory science. The session
was addressed by Prof. Manoj Kumar, Professor, Department of Pharmacoinformatics, National Institute
of Pharmaceutical Education and Research (NIPER), Mohali. Officers and staff of the Department
actively participated in the session.
The session provided a comprehensive overview of the pharmaceutical lifecycle, emphasizing the catalytic
role AI can play at various stages:
Research & Development Phase: Target identification and lead optimization
Pre-clinical Studies: In vitro and in vivo modelling using AI-enabled simulations
Clinical Trials: Improved trial design, patient stratification, and advanced data analytics
Regulatory Review & Approval: Enhanced evidence generation and AI-enabled decision support
systems
Prof. Kumar elaborated on the growing integration of AI in drug discovery, highlighting key
advancements such as prediction of 3D protein structures and drug–target interactions, AI-driven
drug design and de novo molecule generation, and the application of AI in polypharmacology and
multi-target drug development.
He further discussed the use of AI in chemical synthesis and retrosynthetic pathway prediction,
identification of therapeutic targets, and drug repurposing opportunities. Additionally, AI-based
prediction of toxicity, bioactivity, and physicochemical properties is significantly improving early-
stage research outcomes.Prof. Kumar also explained how AI tools are enabling faster and more efficient screening of compounds,
thereby substantially reducing the time and cost associated with early-stage drug discovery.
The webinar emphasized the need for capacity building within government systems to effectively leverage
AI for:
Evidence-based regulatory decision-making
Accelerated approval pathways
Enhanced monitoring of drug safety and post-market surveillance
Strengthening India’s position as a global pharmaceutical leader
The initiative reflects the Department’s continued commitment to fostering innovation, strengthening
regulatory frameworks, and promoting the adoption of emerging technologies to enhance the efficiency
and global competitiveness of India’s pharmaceutical sector.
Strengthening Adaptive Development and Humane Aptitude for National Advancement (Sādhana)
Saptah 2026, being organised from 2 to 8 April 2026, is among the largest collaborative capacity-
building initiatives in India aimed at fostering skills for citizen-centric governance. Spearheaded by the
Department of Personnel and Training, the Capacity Building Commission, and Karmayogi Bharat, the
initiative brings together Central Ministries, States, Union Territories, and training institutions on a
common platform to promote responsive and accountable governance. With the tagline “Ham Bane
Karmayogi”, the initiative also commemorates the Foundation Day of the Capacity Building Commission
and marks five years of Mission Karmayogi, reinforcing the Government’s commitment to building a
future-ready civil service.
***
PC/PM
(Release ID: 2249011) Visitor Counter : 149
Read this release in: ही